Inotiv, inc. and synexa life sciences sign letter of intent to establish center of excellence for biotherapeutics and biomarkers

-- expected to establish a leading global provider of full-spectrum, preclinical and clinical biotherapeutics and biomarker analysis solutions -- -- expected to enhance scale, broaden customer base and create significant cross-selling opportunities --

NOTV Ratings Summary

NOTV Quant Ranking